IP Library Granted Patent US 9,320,784
Granted Patent B2
US 9,320,784 · App. 13/553,137 · Granted Apr 26, 2016

Peptides shared among lethal cancers and therapeutic compositions comprising said peptides

Inventors: Samuel Bogoch (New York, NY); Elenore S. Bogoch (New York, NY); Anne Elenore Borsanyi (New York, NY); Samuel Winston Bogoch (Oakland, CA)
A61K39/0011C07K7/06C07K7/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,320,784
App. No.
13/553,137
Granted
Apr 26, 2016
Kind
B2
Abstract

The present invention provides cancer peptides related to rapid replication and shared among different histological cancer types. The peptides are provided in compositions for interfering with replication in cancer, in preventive and therapeutic vaccines, and in diagnostic applications. The compositions for interfering with replication in cancer are useful for preventing and treating different histological types of cancer including ectodermic, endodermic, and mesodermic cancers as well as cancers arising in association with HIV.

Claims (7)

1. A method of stimulating the immune system of a subject against cancer comprising administering an immunogenic composition that comprises a mixture of at least two peptides, wherein each of said two peptides consists of a sequence selected from a group consisting of SEQ ID NO: 6-13 and SEQ ID NO: 14 and a pharmaceutically acceptable carrier.

2. The method of claim 1 , wherein said immunogenic composition comprises a mixture of at least each of nine peptides consisting of a sequence of SEQ ID NO(s): 6-14.

3. The method of claim 1 , wherein the immune system of a subject is stimulated against cancer in a patient infected with HIV.

4. The method of claim 1 , wherein the immune system of a subject is stimulated against one or more of glioblastoma multiforme, lung cancer, and leukemia.

5. The method of claim 4 , wherein the immune system of said subject is stimulated at least against glioblastoma multiforme cancer.

6. The method of claim 4 , wherein the immune system of said subject is stimulated at least against lung cancer.

7. The method of claim 4 , wherein the immune system of said subject is stimulated at least against leukemia and wherein the mixture comprises SEQ ID NO: 7.

Continuity (5)
Continuation In Part 12581112 · Oct 16, 2009
Continuation In Part 12538027 · Aug 7, 2009
Provisional Application 61609074 · Mar 9, 2012
Provisional Application 61509896 · Jul 20, 2011
Related Publication 20130084303A1 · Apr 4, 2013